Items tagged with Access
Nigeria spends nearly US$1.5 million for procurement of treatment for people with multidrug-resistant TB (post with simple image)
The Nigerian government sanctioned US$1.42 million to procure quality assured Second Line Drugs (SLDs) that will be used to provide treatment for 500 multidrug-resistant TB (MDR-TB) patients. The second line drugs ordered by the government will be delivered by Stop TB Partnership’s Global Drug Facility starting June 2015.
How to access the bedaquiline donation program: step by step (post with simple image)
This is a note for implementers providing a general overview and reviewing the steps they need to take in order to access the drug.
MSF response to announcement of Otsuka’s donation programme for the TB drug delamanid (post with simple image)
MSF continues to express concern over the use of limited-scope donation programmes as a primary means of providing access to new TB drugs in countries affected by drug-resistant TB, as they are not a long-term solution to facilitating scale-up of treatment.
WHO moves to improve access to lifesaving medicines for hepatitis C, drug-resistant TB and cancers (post with simple image)
New WHO Model List of Essential Medicines published; After about 45 years of scarce innovation for TB medicines, 5 new products are included in the List. Four of these, including bedaquiline and delamanid, target multidrug-resistant TB.
Letter from TB community re: intellectual property rights to sutezolid (post with simple image)
The letter urges Johns Hopkins to assure the timely and responsible development of TB drug candidate sutezolid if transferring any intellectual property rights to Sequella.
Lack of medicines in Ukraine a ‘major problem’, says UN (post with simple image)
Millions of people displaced or severely affected by the conflict in Ukraine are in dire need of basic services, with the lack of medicines and vaccines a major concern, a new United Nations (UN) report has warned.
South Africa: Drug stock outs hit more than one in 10 health facilities (post with simple image)
HIV and tuberculosis (TB) drug stock outs have hit about 14 percent of health facilities nationwide in the last nine months, according to a new study released today by civil society coalition the Stop Stock Outs Project.
MSF launches global campaign urging India to protect access to affordable medicines (post with simple image)
Millions of people in developing countries could be affected if India caves in to pressure.
The need to accelerate access to new drugs for multidrug-resistant tuberculosis (post with simple image)
There needs to be a major scale-up of treatment for MDR tuberculosis that matches the scale-ups that have already been achieved in treatments for HIV and drug-susceptible tuberculosis.
The Medicines Patent Pool releases independent feasibility studies on hepatitis C and tuberculosis (post with simple image)
As part of its ongoing consultation processes on the possibility of the Medicines Patent Pool (MPP) expanding into other disease areas, the organisation has published independent feasibility studies exploring the case for potential entry into hepatitis C and tuberculosis.
Page 50 of 65 · Total posts: 0←First 49 50 51 Last→